Cresco Labs Opens Sunnyside Dispensary in Prestonsburg Kentucky

Cresco Labs announced on October 23, 2026, the grand opening of its Sunnyside dispensary in Prestonsburg, Kentucky, which the company described as its 83rd dispensary nationwide.

The store operates at 81 Glynview Plaza in Prestonsburg, in the heart of Eastern Kentucky. In its grand-opening announcement, Cresco said the opening marks a major milestone for Kentucky’s emerging medical cannabis program, with dispensaries now operating in all 11 regions of the Commonwealth for the first time.

“Access is the foundation of any successful medical cannabis program,” Charlie Bachtell, chief executive officer of Cresco Labs, said in the announcement. “Kentucky continues to make meaningful progress, and we’re excited to help build on that momentum. For patients in Eastern Kentucky, this is an important step toward making medical cannabis a practical, accessible treatment option.”

Cresco described the Prestonsburg location as an education-focused shopping experience, with trained Wellness Advisors available to help patients navigate a curated selection of lab-tested products. According to the company, the product selection includes flower for vaporization, tinctures, topicals and edibles. Registered medical cannabis patients can shop in-store or place orders online at sunnyside.shop for pickup.

State Registry Lists the Store as Open Since October 13

The Kentucky Office of Medical Cannabis maintains a registry of open dispensaries that it updated as of October 16, 2026. The state registry identifies the Prestonsburg license holder as BSRKYAPP, LLC, doing business as Sunnyside Prestonsburg, located at 81 Glynview Plaza, Prestonsburg, KY 41653, and records the dispensary as open since October 13, 2026. Cresco’s grand-opening announcement is dated October 23, 2026.

The registry lists each operational dispensary in the Commonwealth with its address and the date it opened. Tree Soft LLC, doing business as The Post Dispensary at 300 N. Main St. in Beaver Dam, is listed as open since January 16, 2026. KYLX Acquisition Company LLC, doing business as Speakeasy Dispensary at 1849 Alysheba Way in Lexington, is listed as open since January 15, 2026. Picasso Cannabis, doing business as Kentucky Alternative Care at 2401-B Bardstown Rd. in Louisville, is listed as open since January 31, 2026. Bluegrass Cannacare LLC, at 6809 Burlington Pike in Florence, is listed as open since February 7, 2026. DHK KY LLC, at 130 W Tiverton Way, Suite 100, in Lexington, is listed as open since October 16, 2026, the date through which the state says the registry is current.

Kentucky’s Medical Cannabis Program

Gov. Andy Beshear signed Senate Bill 47 on March 31, 2023, legalizing medical cannabis in the Commonwealth effective January 1, 2025, according to the Kentucky Office of Medical Cannabis. The office, housed in the Cabinet for Health and Family Services, is charged under KRS Chapter 218B with implementing and administering the program. The office states that its goal is to ensure Kentuckians suffering with serious medical conditions have safe, affordable access to medical cannabis, and it describes the legislation as part of Beshear’s effort to reduce Kentuckians’ reliance on addictive opioids and to provide relief from severe and chronic pain.

As of April 18, 2024, the program had filed 17 regulations establishing the processes and procedures for medical cannabis businesses and registered cardholders, according to the office. The business regulations establish how cultivators, processors, producers, safety compliance facilities and dispensaries will apply, become licensed and operate in the Commonwealth. Regulations covering patients, designated caregivers and practitioners establish the procedures to receive a written certification and a medical cannabis card, along with supply limits and procedures to publish a list of varieties of medical cannabis. On February 5, 2026, the office sent a recommendation to legislative leadership to expand the qualifying medical conditions for medical cannabis.

Cresco established its Kentucky footprint before the Prestonsburg opening. On March 10, 2025, the company announced a management services agreement tied to a Tier 3 cultivation license in the state. The agreement entitles Cresco to manage and operate a cultivation facility with up to 25,000 square feet of canopy, and the company said the arrangement made it one of only two operators of Kentucky’s Tier 3 cultivation licenses. In the same release, Cresco stated that Kentucky’s program includes a maximum of 115,000 square feet of approved canopy space and 48 retail licenses. Citing the MJBiz Factbook 2024, the company said industry analysts forecast the Kentucky market to generate more than $135 million in revenue by 2026, growing to more than $228 million by 2028.

Bachtell said in the March 2025 release that Kentucky represented the company’s first of many opportunities to reinvest free cash flow into what he called high-ROIC growth initiatives as the company expanded into new markets.

Cresco Labs trades on the Canadian Securities Exchange under the symbol CL, on OTCQX under CRLBF and on the Frankfurt Stock Exchange under 6CQ.